Ann Mullally Division of Hematology, Department of Medicine Brigham and Women's Hospital, Harvard Medical School Biography Publications Institution JoVE Articles Ann Mullally has not added a biography. If you are Ann Mullally and would like to personalize this page please email our Author Liaison for assistance. Publications Defining the Requirements for the Pathogenic Interaction Between Mutant Calreticulin and MPL in MPN Blood. Dec, 2017 | Pubmed ID: 29288169 Kinase Inhibitors in the Treatment of Myeloid Malignancies Hematology/oncology Clinics of North America. Aug, 2017 | Pubmed ID: 28673398 The Development and Use of Janus Kinase 2 Inhibitors for the Treatment of Myeloproliferative Neoplasms Hematology/oncology Clinics of North America. Aug, 2017 | Pubmed ID: 28673391 Underlying Mechanisms of the JAK2V617F Mutation in the Pathogenesis of Myeloproliferative Neoplasms Der Pathologe. Nov, 2016 | Pubmed ID: 27796499 Mutant Calreticulin Requires Both Its Mutant C-terminus and the Thrombopoietin Receptor for Oncogenic Transformation Cancer Discovery. Apr, 2016 | Pubmed ID: 26951227 RECQL5 Suppresses Oncogenic JAK2-Induced Replication Stress and Genomic Instability Cell Reports. Dec, 2015 | Pubmed ID: 26686625 Depletion of Jak2V617F Myeloproliferative Neoplasm-propagating Stem Cells by Interferon-α in a Murine Model of Polycythemia Vera Blood. May, 2013 | Pubmed ID: 23487027 كريسبر/Cas9 باستخدام الجينات للتحقيق في نشاط النمطان Calreticulin المسخ في الخلايا المكونة للدم سيتوكين تعتمد على تحرير Nouran S. Abdelfattah1, Ann Mullally1,2,3 1Division of Hematology, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, 2Broad Institute, 3Dana-Farber Cancer Institute, Harvard Medical School JoVE 56726 Cancer Research
كريسبر/Cas9 باستخدام الجينات للتحقيق في نشاط النمطان Calreticulin المسخ في الخلايا المكونة للدم سيتوكين تعتمد على تحرير Nouran S. Abdelfattah1, Ann Mullally1,2,3 1Division of Hematology, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, 2Broad Institute, 3Dana-Farber Cancer Institute, Harvard Medical School JoVE 56726 Cancer Research
